• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远距离雌激素反应元件的扩增使与乳腺癌中他莫昔芬耐药相关的靶基因失调控。

Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer.

机构信息

Department of Molecular Medicine/Institute of Biotechnology, Cancer Therapy and Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78245, USA.

出版信息

Cancer Cell. 2013 Aug 12;24(2):197-212. doi: 10.1016/j.ccr.2013.07.007.

DOI:10.1016/j.ccr.2013.07.007
PMID:23948299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3890247/
Abstract

A causal role of gene amplification in tumorigenesis is well known, whereas amplification of DNA regulatory elements as an oncogenic driver remains unclear. In this study, we integrated next-generation sequencing approaches to map distant estrogen response elements (DEREs) that remotely control the transcription of target genes through chromatin proximity. Two densely mapped DERE regions located on chromosomes 17q23 and 20q13 were frequently amplified in estrogen receptor-α-positive luminal breast cancer. These aberrantly amplified DEREs deregulated target gene expression potentially linked to cancer development and tamoxifen resistance. Progressive accumulation of DERE copies was observed in normal breast progenitor cells chronically exposed to estrogenic chemicals. These findings may extend to other DNA regulatory elements, the amplification of which can profoundly alter target transcriptome during tumorigenesis.

摘要

基因扩增在肿瘤发生中的因果作用是众所周知的,而 DNA 调控元件的扩增作为致癌驱动因素尚不清楚。在这项研究中,我们整合了下一代测序方法来绘制远程雌激素反应元件 (DEREs),这些元件通过染色质接近远程控制靶基因的转录。两个位于染色体 17q23 和 20q13 上的密集映射的 DERE 区域在雌激素受体-α阳性腔乳腺癌中经常扩增。这些异常扩增的 DERE 使靶基因表达失控,可能与癌症发展和他莫昔芬耐药有关。在长期暴露于雌激素类化学物质的正常乳腺祖细胞中观察到 DERE 拷贝的逐渐积累。这些发现可能扩展到其他 DNA 调控元件,其扩增在肿瘤发生过程中会极大地改变靶转录组。

相似文献

1
Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer.远距离雌激素反应元件的扩增使与乳腺癌中他莫昔芬耐药相关的靶基因失调控。
Cancer Cell. 2013 Aug 12;24(2):197-212. doi: 10.1016/j.ccr.2013.07.007.
2
Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells.雌激素受体α阳性乳腺癌细胞中雌激素反应性转录的时空控制
Oncogene. 2016 May 5;35(18):2379-89. doi: 10.1038/onc.2015.298. Epub 2015 Aug 24.
3
OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.OCT-4:一种新型雌激素受体-α共激活因子,可促进乳腺癌细胞对他莫昔芬产生耐药性。
Oncogene. 2016 Nov 3;35(44):5722-5734. doi: 10.1038/onc.2016.105. Epub 2016 Apr 11.
4
Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.鉴定 BCAR4,一种导致人类乳腺癌细胞内分泌抵抗的新型致癌基因。
J Cell Physiol. 2011 Jul;226(7):1741-9. doi: 10.1002/jcp.22503.
5
Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance.氧化应激促进他莫昔芬诱导的乳腺癌细胞杀伤:对他莫昔芬治疗及耐药性的影响
Sci Rep. 2016 Feb 17;6:21164. doi: 10.1038/srep21164.
6
Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.BRCA1表达降低通过改变雌激素受体-共调节因子相互作用赋予乳腺癌细胞对他莫昔芬的耐药性。
Oncogene. 2009 Jan 29;28(4):575-86. doi: 10.1038/onc.2008.405. Epub 2008 Nov 10.
7
c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer.c-Jun/AP-1 过表达重编程 ERα 信号转导与 ERα 阳性乳腺癌他莫昔芬反应相关。
Oncogene. 2018 May;37(19):2586-2600. doi: 10.1038/s41388-018-0165-8. Epub 2018 Feb 22.
8
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen.组蛋白脱乙酰酶抑制剂曲古抑菌素A使雌激素受体α阴性乳腺癌细胞对他莫昔芬敏感。
Oncogene. 2004 Mar 4;23(9):1724-36. doi: 10.1038/sj.onc.1207315.
9
Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.Y 盒结合蛋白-1 表达的改变可改变雌激素受体阳性乳腺癌对内分泌治疗的反应。
Breast Cancer Res Treat. 2012 May;133(1):145-59. doi: 10.1007/s10549-011-1731-8. Epub 2011 Aug 24.
10
Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.雌激素受体β对 ERα/PR 阴性乳腺癌中 BCRP 介导的耐药性和细胞增殖的有害影响。
FEBS J. 2013 Dec;280(23):6128-40. doi: 10.1111/febs.12533. Epub 2013 Oct 8.

引用本文的文献

1
Topological regulation of the estrogen transcriptional response by ZATT-mediated inhibition of TOP2B activity.通过ZATT介导的TOP2B活性抑制对雌激素转录反应的拓扑调节
bioRxiv. 2024 Jan 23:2024.01.22.576640. doi: 10.1101/2024.01.22.576640.
2
Long-range gene regulation in hormone-dependent cancer.激素依赖性癌症的长程基因调控。
Nat Rev Cancer. 2023 Oct;23(10):657-672. doi: 10.1038/s41568-023-00603-4. Epub 2023 Aug 3.
3
ERα-associated translocations underlie oncogene amplifications in breast cancer.雌激素受体α相关易位导致乳腺癌中癌基因扩增。
Nature. 2023 Jun;618(7967):1024-1032. doi: 10.1038/s41586-023-06057-w. Epub 2023 May 17.
4
2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity.2-羟戊二酸使染色质调控景观和谱系保真度不稳定,以促进细胞异质性。
Cell Rep. 2022 Jan 11;38(2):110220. doi: 10.1016/j.celrep.2021.110220.
5
Genome-Wide Estrogen Receptor Activity in Breast Cancer.全基因组雌激素受体活性在乳腺癌中的作用。
Endocrinology. 2021 Feb 1;162(2). doi: 10.1210/endocr/bqaa224.
6
An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.一种 H3K4me3 阅读器,BAP18 作为 COMPASS 样核心亚基的接头,共同激活 ERα 作用,并与乳腺癌中抗雌激素的敏感性相关。
Nucleic Acids Res. 2020 Nov 4;48(19):10768-10784. doi: 10.1093/nar/gkaa787.
7
The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells.内分泌抵抗型乳腺癌细胞对 EGFR/HER2 抑制的差异化反应的三维基因组景观。
Biochim Biophys Acta Gene Regul Mech. 2020 Nov;1863(11):194631. doi: 10.1016/j.bbagrm.2020.194631. Epub 2020 Sep 19.
8
Modeling and analysis of Hi-C data by HiSIF identifies characteristic promoter-distal loops.通过 HiSIF 对 Hi-C 数据进行建模和分析,确定了具有特征的启动子-远端环。
Genome Med. 2020 Aug 12;12(1):69. doi: 10.1186/s13073-020-00769-8.
9
Loss of ZIP facilitates JAK2-STAT3 activation in tamoxifen-resistant breast cancer.ZIP 的缺失促进了他莫昔芬耐药乳腺癌中 JAK2-STAT3 的激活。
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15047-15054. doi: 10.1073/pnas.1910278117. Epub 2020 Jun 12.
10
ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.雌激素受体α相关染色体重排增强了腔面乳腺癌 17q11.1-q24.1 染色体上的一致基因转录。
BMC Med Genomics. 2020 May 14;13(1):69. doi: 10.1186/s12920-020-0729-7.

本文引用的文献

1
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.胰腺癌基因组揭示了神经导向途径基因的异常。
Nature. 2012 Nov 15;491(7424):399-405. doi: 10.1038/nature11547. Epub 2012 Oct 24.
2
Comprehensive molecular portraits of human breast tumours.人类乳腺肿瘤的全面分子特征图谱。
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
3
Cancer genetics and epigenetics: two sides of the same coin?癌症遗传学与表观遗传学:同一枚硬币的两面?
Cancer Cell. 2012 Jul 10;22(1):9-20. doi: 10.1016/j.ccr.2012.06.008.
4
Amplified loci on chromosomes 8 and 17 predict early relapse in ER-positive breast cancers.染色体 8 和 17 上的扩增位点可预测 ER 阳性乳腺癌的早期复发。
PLoS One. 2012;7(6):e38575. doi: 10.1371/journal.pone.0038575. Epub 2012 Jun 13.
5
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.2000 个乳腺肿瘤的基因组和转录组结构揭示了新的亚群。
Nature. 2012 Apr 18;486(7403):346-52. doi: 10.1038/nature10983.
6
DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes.DNA 复制时间和长程 DNA 相互作用预测癌症基因组的突变景观。
Nat Biotechnol. 2011 Nov 20;29(12):1103-8. doi: 10.1038/nbt.2030.
7
Subtype and pathway specific responses to anticancer compounds in breast cancer.乳腺癌中抗癌化合物的亚型和途径特异性反应。
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9. doi: 10.1073/pnas.1018854108. Epub 2011 Oct 14.
8
DNA secondary structures and epigenetic determinants of cancer genome evolution.DNA 二级结构和癌症基因组进化的表观遗传决定因素。
Nat Struct Mol Biol. 2011 Jul 3;18(8):950-5. doi: 10.1038/nsmb.2089.
9
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.用于预测紫杉烷-蒽环类化疗治疗浸润性乳腺癌的反应和生存的基因组预测因子。
JAMA. 2011 May 11;305(18):1873-81. doi: 10.1001/jama.2011.593.
10
The genomic complexity of primary human prostate cancer.原发性人类前列腺癌的基因组复杂性。
Nature. 2011 Feb 10;470(7333):214-20. doi: 10.1038/nature09744.